Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiedler

Showing results (61-70 of 195) with videos related to

Pageof 20
Sort By:
Case Reports in Hematology|November 3, 2025
Acute Lymphoblastic Leukemia Characterized by Rare <i>BCR</i>::<i>FGFR1</i> Translocation: A Case Report With Literature ReviewMaximilian Al-Bazaz, Anika Forstreuter, Ibrahim Hammada, et al.
International Journal of Molecular Sciences|January 23, 2020
Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate CarcinomaLeticia Oliveira-Ferrer, Karin Milde-Langosch, Kathrin Eylmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416Gunter Schuch, Maike de Wit, Jan Höltje, et al.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Acta Oncologica (Stockholm, Sweden)|December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Oncotarget|April 19, 2017
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemiaEmily-Marie Latuske, Hauke Stamm, Marianne Klokow, et al.
Zeitschrift Fur Gastroenterologie|January 10, 2018
Acute hepatitis as a prequel to very severe aplastic anemiaChristina Weiler-Normann, Johannes Hartl, Sören Weidemann, et al.
Frontiers in Oncology|January 21, 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unitPanagiotis Karagiannis, Felix Klingler, Viktor Arelin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survivalSonja Loges, Gerhard Heil, Melanie Bruweleit, et al.
Pageof 20

Showing results (61-70 of 195) with videos related to

Sort By:
Pageof 20
Case Reports in Hematology|November 3, 2025
Acute Lymphoblastic Leukemia Characterized by Rare <i>BCR</i>::<i>FGFR1</i> Translocation: A Case Report With Literature ReviewMaximilian Al-Bazaz, Anika Forstreuter, Ibrahim Hammada, et al.
International Journal of Molecular Sciences|January 23, 2020
Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate CarcinomaLeticia Oliveira-Ferrer, Karin Milde-Langosch, Kathrin Eylmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416Gunter Schuch, Maike de Wit, Jan Höltje, et al.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Acta Oncologica (Stockholm, Sweden)|December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Oncotarget|April 19, 2017
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemiaEmily-Marie Latuske, Hauke Stamm, Marianne Klokow, et al.
Zeitschrift Fur Gastroenterologie|January 10, 2018
Acute hepatitis as a prequel to very severe aplastic anemiaChristina Weiler-Normann, Johannes Hartl, Sören Weidemann, et al.
Frontiers in Oncology|January 21, 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unitPanagiotis Karagiannis, Felix Klingler, Viktor Arelin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survivalSonja Loges, Gerhard Heil, Melanie Bruweleit, et al.
Pageof 20